Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets, addressing diseases from inflammatory disorders to oncology. We strive to unlock the potential of nucleic acid therapeutics with our 3-dimensional, spherical nucleic acid (SNA™) constructs. SNA constructs have the potential to overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues.
We seek employees who have the passion to help us drive this innovative technology forward to the patients in need and thrive in a fast-paced atmosphere. We are always interested in receiving resumes from highly skilled and experienced candidates.